Time slot's time in Taipei (GMT+8)
- 2024/10/5
- Room 101
- Type: Physical
- SECC Ⅱ-1
Repsiratory
- TIME
- TOPIC
- SPEAKER
- MODERATOR
- 14:00-14:25
- Respiratory Microbiome in Mechanically Ventilated Patients
- SPEAKER:
黃虹綾(Hung-Ling Huang)
Taiwan (台灣)
- MODERATOR:
- Dr. 黃虹綾(Hung-Ling Huang)
- Associate Professor, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
Biography:
I am Hung-Ling Huang, a pulmonologist in Kaohsiung Medical University Hospital and an associate professor of Internal medicine at Kaohsiung Medical University in Taiwan. I am also the director of the Taiwan Society of Tuberculosis and Lung Disease. My research primarily focuses on pulmonary infections, particularly pulmonary tuberculosis, latent tuberculosis infection, nontuberculous mycobacterial pulmonary disease, and pulmonary aspergillosis. In recent years, I have participated in various studies to investigate the role of gut and respiratory microbiota in various pulmonary infectious disease, aiming to identify potential biomarkers for disease progression and novel therapeutic targets. I also have executed many research projects of pulmonary infection as principal investigator and participated in randomized clinical trials and cross-nations studies.
I am Hung-Ling Huang, a pulmonologist in Kaohsiung Medical University Hospital and an associate professor of Internal medicine at Kaohsiung Medical University in Taiwan. I am also the director of the Taiwan Society of Tuberculosis and Lung Disease. My research primarily focuses on pulmonary infections, particularly pulmonary tuberculosis, latent tuberculosis infection, nontuberculous mycobacterial pulmonary disease, and pulmonary aspergillosis. In recent years, I have participated in various studies to investigate the role of gut and respiratory microbiota in various pulmonary infectious disease, aiming to identify potential biomarkers for disease progression and novel therapeutic targets. I also have executed many research projects of pulmonary infection as principal investigator and participated in randomized clinical trials and cross-nations studies.